Pursuant to its responsibilities under the World Anti-Doping Code (Code), WADA publishes annually two sets of testing figures.
The first set reported by Anti-Doping Organizations (ADOs) is on results management from testing, and the second set is reported by the WADA accredited anti-doping laboratories on analyses performed.
In regards to the Testing Figures, section 14.4 of the Code states that “Anti-Doping Organizations shall, at least annually, publish publicly a general statistical report of their Doping Control activities with a copy provided to WADA”.
Code Section 14.5 further states that “WADA shall act as the central clearing house for Doping Control Testing data” from Anti-Doping Organizations and “shall, at least annually, publish statistical reports summarizing such information”.
In accordance with these Code requirements, WADA has requested that all International Federations (IFs) and National Anti-Doping Organizations (NADOs) submit their testing data, and has published the data that has been received to date.
The 2011 Laboratory Testing Figures includes analyses conducted by the WADA accredited laboratories for in- and out-of-competition testing. There were 33 WADA accredited laboratories in 2011.
In 2011, the number of samples analyzed decreased by approximately 15,000 compared to 2010, but in terms of the percentage of overall Adverse Analytical Findings (AAFs) reported, the 2011 percentage of 1.19% is the highest since 2008, which was when the number of AAFs reported was compiled separately from the number of Atypical Findings (ATFs).
From 2010 to 2011, there also was a slight increase in the combined reporting of AAFs and ATFs - from 1.87% in 2010 to 2.00% in 2011.
It is important to note that the data for AAFs (i.e. the presence of prohibited substances or methods in samples) and ATFs (i.e. the presence of prohibited substances or methods requiring further investigation before potentially becoming an AAF) is only the analytical findings reported by the laboratories and all are subject to the results management process conducted by ADOs, which includes matching with Therapeutic Use Exemptions and longitudinal studies.
Therefore, the number of AAFs and ATFs reported by laboratories may not correspond with the number of cases sanctioned (Anti-Doping Rule Violations) by ADOs.
In order to further improve the provision of ADO figures, WADA continues to promote the use of Anti-Doping Administration & Management System (ADAMS) by all ADOs.
By requiring all WADA-accredited laboratories to report all testing into ADAMS, steps have already been taken to enhance the effectiveness of doping control reporting, and this will continue to be enhanced going forward by attributing laboratory figures to individual ADOs.
Click here for the ADO Testing Figures page.
Click here for the Laboratory Testing Figures page.
Click here for a Q&A on the Laboratory Testing Figures.